Featured Research

from universities, journals, and other organizations

In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia

Date:
February 19, 2014
Source:
American Society for Gastrointestinal Endoscopy
Summary:
New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using targeted biopsies of abnormal mucosa to reduce unnecessary mucosal biopsies and potentially reduce costs. It may also positively influence patient care by changing the plan for immediate endoscopic management.

New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using targeted biopsies of abnormal mucosa to reduce unnecessary mucosal biopsies and potentially reduce costs. It may also positively influence patient care by changing the plan for immediate endoscopic management. The study appears in the February issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).

Barrett's esophagus (BE) is a precancerous change in the epithelial lining of the esophagus that is associated with the development of esophageal cancer. The current best, though imperfect, marker of neoplastic progression is dysplasia (abnormality in cells which have undergone early changes on a path toward possible malignancy) detected in mucosal biopsy specimens of the lining of the esophagus obtained at the time of endoscopy. High-grade dysplasia is associated with a high rate of progression to invasive esophageal cancer. Detection and pathologic confirmation of early BE neoplasia (high-grade dysplasia or early esophageal cancer) is important because endoscopic therapy at this point is highly successful. Unfortunately, neoplasia in BE may not be evident even with only endoscopic inspection, so the current standard of care is endoscopic surveillance with high-quality white-light endoscopy using systematic 4-quadrant biopsies every 1 to 2 cm of BE length and targeted biopsies of any mucosal irregularities. A large number of biopsies may be required using this random biopsy method, resulting in high cost and increased time. This method has a low (1 percent to 10 percent) diagnostic yield for neoplasia and may result in lower adherence to practice guidelines.

Confocal laser endomicroscopy (CLE) is a relatively new endoscopic imaging technique that combines endoscopy and microscopic imaging of the gastrointestinal (GI) mucosa (the superficial lining of the GI tract). A previous single-center, randomized, crossover study, demonstrated a greater diagnostic yield for the detection of BE neoplasia with an in vivo fluorescein-aided endoscope-based CLE system (eCLE).

"Our study compared the diagnostic yield and accuracy of high definition white-light endoscopy (HDWLE) and random biopsy with that of HDWLE plus real-time eCLE imaging and targeted tissue sampling of BE, and determined the impact of in vivo eCLE on real-time clinical decision making in patients with BE," said study lead author Marcia Irene Canto, MD, MHS, FASGE, Johns Hopkins University, Baltimore, Maryland. "We found that real-time eCLE and targeted biopsy after HDWLE can improve the diagnostic yield and accuracy for neoplasia and significantly impact in vivo decision making by altering the diagnosis and guiding therapy."

Methods

This was a multicenter, randomized, controlled trial of 192 adult patients with BE undergoing routine surveillance or referred for early neoplasia from February 2010 to December 2012 at academic medical centers. The researchers' objective was to compare high-definition white-light endoscopy (HDWLE) alone with random biopsy (RB) and HDWLE plus eCLE and targeted biopsy (TB) for diagnosis of BE neoplasia. Patients were randomized to HDWLE plus RB (group 1) or HDWLE with eCLE and TB (group 2). Real-time diagnoses and management plans were recorded after HDWLE in both groups and after eCLE in group 2. Blinded expert pathology diagnosis was the reference standard. The main outcomes were diagnostic yield, performance characteristics, and clinical impact.

Results

HDWLE plus eCLE and TB (group 2) led to a lower number of mucosal biopsies and higher diagnostic yield for neoplasia (34 percent vs 7 percent), compared with HDWLE and RB (group 1) but with comparable accuracy. HDWLE plus eCLE and TB tripled the diagnostic yield for neoplasia (22 percent vs 6 percent) and would have obviated the need for any biopsy in 65 percent of patients. The addition of eCLE to HDWLE increased the sensitivity for neoplasia detection to 96 percent from 40 percent without significant reduction in specificity. In vivo CLE changed the treatment plan in 36 percent of patients. An eCLE was performed successfully and safely in all patients. There were no adverse reactions to fluorescein administration.

The researchers noted several limitations including that the study was only at academic centers with highly experienced endoscopists. The results may not be generalizable to community-based physicians, less-experienced practitioners and nonacademic practices. Second, they used the eCLE system, and their findings may not be generalizable to other pCLE systems. Also, the endoscopists were not blinded to prior endoscopy and pathology results because these were necessary for standard medical care and in vivo decision making regarding biopsy or EMR.

The researchers concluded that the addition of in vivo imaging with eCLE to HDWLE is associated with improved targeting of neoplasia, a decrease in unnecessary mucosal biopsies and a significant change in diagnosis and management plans in patients with BE. The approach of real-time CLE diagnosis and imaging-guided therapy represents a potential paradigm shift in BE surveillance. Research studies are needed to address training in CLE, comparative effectiveness studies of advanced endoscopic imaging techniques, the role of imaging-guided therapy and advances in CLE devices and contrast agents.

In an accompanying editorial, Manuel Berzosa, MD and Michael B. Wallace, MD, MPH, Mayo Clinic, Jacksonville, Florida, stated, "This is an important study for Barrett's esophagus surveillance because it demonstrates that a targeted biopsy strategy using endoscope based confocal laser endomicroscopy can be a superior alternative to random biopsy protocols."


Story Source:

The above story is based on materials provided by American Society for Gastrointestinal Endoscopy. Note: Materials may be edited for content and length.


Journal Reference:

  1. Marcia Irene Canto, Sharmila Anandasabapathy, William Brugge, Gary W. Falk, Kerry B. Dunbar, Zhe Zhang, Kevin Woods, Jose Antonio Almario, Ursula Schell, John Goldblum, Anirban Maitra, Elizabeth Montgomery, Ralf Kiesslich. In vivo endomicroscopy improves detection of Barrett's esophagus–related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointestinal Endoscopy, 2014; 79 (2): 211 DOI: 10.1016/j.gie.2013.09.020

Cite This Page:

American Society for Gastrointestinal Endoscopy. "In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia." ScienceDaily. ScienceDaily, 19 February 2014. <www.sciencedaily.com/releases/2014/02/140219174939.htm>.
American Society for Gastrointestinal Endoscopy. (2014, February 19). In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2014/02/140219174939.htm
American Society for Gastrointestinal Endoscopy. "In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia." ScienceDaily. www.sciencedaily.com/releases/2014/02/140219174939.htm (accessed April 17, 2014).

Share This



More Matter & Energy News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

German Researchers Crack Samsung's Fingerprint Scanner

German Researchers Crack Samsung's Fingerprint Scanner

Newsy (Apr. 16, 2014) German researchers have used a fake fingerprint made from glue to bypass the fingerprint security system on Samsung's new Galaxy S5 smartphone. Video provided by Newsy
Powered by NewsLook.com
Porsche CEO Says Supercar Is Not Dead: Cue the Spyder 918

Porsche CEO Says Supercar Is Not Dead: Cue the Spyder 918

TheStreet (Apr. 16, 2014) The Porsche Spyder 918 proves that, in an automotive world obsessed with fuel efficiency, the supercar is not dead. Porsche North America CEO Detlev von Platen attributes the brand's consistent sales growth -- 21% in 2013 -- with an investment in new technology and expanded performance dynamics. The hybrid Spyder 918 has 887 horsepower and 944 lb-ft of torque, but it can run 18 miles on just an electric charge. The $845,000 vehicle is not a consumer-targeted vehicle but a brand statement. Video provided by TheStreet
Powered by NewsLook.com
Industry's Optimism Shines At New York Auto Show

Industry's Optimism Shines At New York Auto Show

Newsy (Apr. 16, 2014) After seeing auto sales grow last month, there's plenty for the industry to celebrate as it rolls out its newest designs. Video provided by Newsy
Powered by NewsLook.com
Ford Mustang Fetes Its 50th Atop Empire State Building

Ford Mustang Fetes Its 50th Atop Empire State Building

AFP (Apr. 16, 2014) Ford celebrated the 50th birthday of its beloved Mustang by displaying a new model of the convertible on top of the Empire State Building in New York. Duration: 00:28 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins